Sensitivity of diffusion-and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%

Stroke

Volumn 46, Issue 1, 2015, Pages 98-101

  Simonsen, Claus Z ^a   Madsen, Mette H ^b   Schmitz, Marie L ^a   Mikkelsen, Irene K ^a   Fisher, Marc ^c   Andersen, Grethe ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Department of Neuroradiology ^*  (Denmark)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

diffusion magnetic resonance imaging; perfusion imaging; stroke; tissue type plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN CIRCULATION; BRAIN ISCHEMIA; BRAIN PERFUSION; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PREDICTIVE VALUE; RANKIN SCALE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; BRAIN ANGIOGRAPHY; COHORT ANALYSIS; COMPLICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; STROKE;

AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84920275691     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007107     Document Type: Article

References (19)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004;292:1823-1830.
3. Lansberg MG, Albers GW, Beaulieu C, Marks MP. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology. 2000;54:1557-1561.
4. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293-298.
5. Fiebach J, Jansen O, Schellinger P, Knauth M, Hartmann M, Heiland S, et al. Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke. Neuroradiology. 2001;43:628-632.
6. Brunser AM, Hoppe A, Illanes S, Díaz V, Muñoz P, Cárcamo D, et al. Accuracy of diffusion-weighted imaging in the diagnosis of stroke in patients with suspected cerebral infarct. Stroke. 2013;44:1169-1171.
7. Oppenheim C, Stanescu R, Dormont D, Crozier S, Marro B, Samson Y, et al. False-negative diffusion-weighted MR fndings in acute ischemic stroke. AJNR Am J Neuroradiol. 2000;21:1434-1440.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classifcation of subtype of acute ischemic stroke. Defnitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.
9. Kang DW, Chalela JA, Dunn W, Warach S; NIH-Suburban Stroke Center Investigators. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke. 2005;36:1939-1943.
10. Schellinger PD, Thomalla G, Fiehler J, Köhrmann M, Molina CA, Neumann-Haefelin T, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke. 2007;38:2640-2645.
11. Köhrmann M, Jüttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol. 2006;5:661-667.
12. Yoo SH, Kwon SU, Lee DH, Kim SJ, Kim JS, Kang DW. Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke. J Neurol Sci. 2010;294:119-123.
13. Bang OY, Lee PH, Heo KG, Joo US, Yoon SR, Kim SY. Specifc DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry. 2005;76:1222-1228.
14. Doubal FN, Dennis MS, Wardlaw JM. Characteristics of patients with minor ischaemic strokes and negative MRI: a cross-sectional study. J Neurol Neurosurg Psychiatry. 2011;82:540-542.
15. Giles MF, Albers GW, Amarenco P, Arsava EM, Asimos AW, Ay H, et al. Early stroke risk and ABCD2 score performance in tissue-vs time-defned TIA: a multicenter study. Neurology. 2011;77:1222-1228.
16. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
17. Bulut HT, Yildirim A, Ekmekci B, Eskut N, Gunbey HP. False-negative diffusion-weighted imaging in acute stroke and its frequency in anterior and posterior circulation ischemia. J Comput Assist Tomogr. 2014;38:627-633.
18. Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, et al. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Stroke. 2011;42:1251-1254.
19. Rosso C, Drier A, Lacroix D, Mutlu G, Pires C, Lehéricy S, et al. Diffusion-weighted MRI in acute stroke within the frst 6 hours: 1.5 or 3.0 Tesla? Neurology. 2010;74:1946-1953.